Advaxis Inc (ADXS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

305 COLLEGE ROAD EAST PRINCETON,, NJ 08540

Data as of 2020-10-17
Market Cap26.862 Million Shares Outstanding66.227 Million Avg 30-day Volume1.382 Million
P/E Ratio Dividend Yield EPS-0.49
Price/Sales105.755 Price cash flow ratio Price free cash flow ratio-1.0
Book Value0.48 Price to Tangible Book1.0 Alpha-0.09
Short Interest Ratio % Short Interest to Float R-squared0.245607
BETA3.40136 52-week High/Low1.48 / 0.2625 Stddev0.294753
View SEC Filings from ADXS instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 35 33 6.06% 8 (0.52%) 7 (0.45%) 14.29%
13F shares: 7.154 Million 6.932 Million 3.21% 4.062 Million 4.098 Million -0.89%
% Ownership 11.6129 11.5056 0.93% 6.5926 6.8023 -3.08%
New Positions: 9 8 12.5% 2 2 0.0%
Increased Positions 8 10 -20.0% 1
Closed Positions 6 7 -14.29% 1 4 -75.0%
Reduced Positions 8 3 166.67% 4 2 100.0%
Total Calls 0 0
Total Puts 0 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ADXS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADXS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PATTON JAMES P

  • Director
0 2020-05-04 1

APPEL RONI

  • Director
0 2020-05-04 2

BERMAN RICHARD J

  • Director
0 2020-05-04 1

SIDRANSKY DAVID

  • Director
0 2020-05-04 1

KHLEIF SAMIR N

  • Director
0 2020-05-04 1

GUTIERREZ ANDRES EXECUTIVE VICE PRESIDENT & CMO

  • Officer
0 2020-05-04 1

BERLIN KENNETH A PRESIDENT AND CEO

  • Officer
0 2020-05-04 1

HENDERSON MOLLY EXECUTIVE VICE PRESIDENT & CFO

  • Officer
0 2020-05-04 1

PETIT ROBERT CHIEF SCIENTIFIC OFFICER

  • Officer
231,206 2018-11-05 0

LOMBARDO ANTHONY A INTERIM CEO

  • Officer
81,852 2018-04-17 0

BONSTEIN SARA CHIEF FINANCIAL OFFICER

  • Officer
226,670 2018-03-29 0

MCKEARN THOMAS J

  • Director
0 2017-11-02 0

RIDGE THOMAS J

  • Director
0 2017-11-02 0

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2017-10-11 0

O'CONNOR DANIEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
618,352 2017-06-30 0

MAYES, GREGORY T.

  • Director
103,841 2016-12-30 0

MAURO DAVID J CHIEF MEDICAL OFFICER

  • Officer
166,271 2015-12-31 0

FRENCH CHRISTY LEE VP-REGULATORY, MEDICAL AFFAIRS

  • Officer
71,938 2014-12-31 0

MOORE THOMAS A

  • FORMER DIRECTOR
176,462 2014-07-17 0

ROSENBLUM MARK J CHIEF FINANCIAL OFFICER

  • Officer
113,774 2014-01-31 0

ROTHMAN JOHN F EXEC VP OF SCIENCE AND OPS

  • Officer
0 2011-11-08 0

COBB FREDRICK D VICE PRESIDENT FINANCE

  • Officer
0 2009-07-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments